Cargando…

Small molecule targeting FOXM1 DNA binding domain exhibits anti-tumor activity in ovarian cancer

FOXM1 is a potent oncogenic transcription factor essential for cancer initiation, progression, and drug resistance. FOXM1 regulatory network is a major predictor of adverse outcomes in various human cancers. Inhibition of FOXM1 transcription factor function is a potential strategy in cancer treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Zaixin, Xue, Si-tu, Gao, Yan, Li, Yingwei, Zhou, Ziying, Wang, Jing, Li, Zhuorong, Liu, Zhaojian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184618/ https://www.ncbi.nlm.nih.gov/pubmed/35680842 http://dx.doi.org/10.1038/s41420-022-01070-w

Ejemplares similares

Structure-based virtual screening identified novel FOXM1 inhibitors as the lead compounds for ovarian cancer
por: Zhou, Zi-Ying, et al.
Publicado: (2022)

Suppression of the FOXM1 transcriptional program via novel small molecule inhibition
por: Gormally, Michael V., et al.
Publicado: (2014)

Domain-based small molecule binding site annotation
por: Snyder, Kevin A, et al.
Publicado: (2006)

Mapping small molecule binding data to structural domains
por: Kruger, Felix A, et al.
Publicado: (2012)

Small molecule inhibition of FOXM1: How to bring a novel compound into genomic context
por: Marsico, Giovanni, et al.
Publicado: (2014)

Identifying Small‐Molecule Binding Sites for Epigenetic Proteins at Domain–Domain Interfaces
por: Bowkett, David, et al.
Publicado: (2018)

Splicing Factor DDX23, Transcriptionally Activated by E2F1, Promotes Ovarian Cancer Progression by Regulating FOXM1
por: Zhao, Chen, et al.
Publicado: (2021)

A Novel Sulfonyl-Based Small Molecule Exhibiting Anti-cancer Properties
por: El-Kadiry, Abed El-Hakim, et al.
Publicado: (2020)

Anti-cancer small molecule JP-8g exhibits potent in vivo anti-inflammatory activity
por: Sun, Yulong, et al.
Publicado: (2014)

FOXM1: Functional Roles of FOXM1 in Non-Malignant Diseases
por: Zhang, Zhenwang, et al.
Publicado: (2023)

Identification of new small molecules as dual FoxM1 and Hsp70 inhibitors using computational methods
por: Alimardan, Zahra, et al.
Publicado: (2022)

Bioinformatics driven discovery of small molecule compounds that modulate the FOXM1 and PPARA pathway activities in breast cancer
por: Huang, Shujun, et al.
Publicado: (2022)

Effect of taxol on the expression of FoxM1 ovarian cancer-associated gene
por: LIU, ZENG, et al.
Publicado: (2016)

Image Translation by Domain-Adversarial Training
por: Li, Zhuorong, et al.
Publicado: (2018)

Structural features of the protein kinase domain and targeted binding by small-molecule inhibitors
por: Arter, Chris, et al.
Publicado: (2022)

Identification of Small Molecule Ligand Binding Sites On and In the ARNT PAS-B Domain
por: Xu, Xingjian, et al.
Publicado: (2023)

Notch1 and Notch4 core binding domain peptibodies exhibit distinct ligand-binding and anti-angiogenic properties
por: Sargis, Timothy, et al.
Publicado: (2022)

Novel single-domain antibodies against the EGFR domain III epitope exhibit the anti-tumor effect
por: Chen, Tao, et al.
Publicado: (2020)

Rad50 promotes ovarian cancer progression through NF‐κB activation
por: Li, Yinuo, et al.
Publicado: (2021)

Synergistic anti-leukemic activity of imatinib in combination with a small molecule Grb2 SH2 domain binding antagonist
por: Zhang, Manchao, et al.
Publicado: (2013)

A small molecule inhibitor of ER-to-cytosol protein dislocation exhibits anti-dengue and anti-Zika virus activity
por: Ruan, Jingjing, et al.
Publicado: (2019)

Expression and functional characterization of FOXM1 in non-small cell lung cancer
por: Zhang, Yan, et al.
Publicado: (2018)

FOXM1 Modulates Cisplatin Sensitivity by Regulating EXO1 in Ovarian Cancer
por: Zhou, Jinhua, et al.
Publicado: (2014)

FOXM1: A Multifunctional Oncoprotein and Emerging Therapeutic Target in Ovarian Cancer
por: Liu, Cassie, et al.
Publicado: (2021)

FOXM1 binds directly to non-consensus sequences in the human genome
por: Sanders, Deborah A., et al.
Publicado: (2015)

Characterization of CADD522, a small molecule that inhibits RUNX2-DNA binding and exhibits antitumor activity
por: Kim, Myoung Sook, et al.
Publicado: (2017)

Quinoline-based clioquinol and nitroxoline exhibit anticancer activity inducing FoxM1 inhibition in cholangiocarcinoma cells
por: Chan-on, Waraporn, et al.
Publicado: (2015)

Structure of the FoxM1 DNA-recognition domain bound to a promoter sequence
por: Littler, D. R., et al.
Publicado: (2010)

Discovery and characterization of small molecules targeting the DNA-binding ETS domain of ERG in prostate cancer
por: Butler, Miriam S., et al.
Publicado: (2017)

Small Molecules Targeting SARS-CoV-2 Spike Glycoprotein Receptor-Binding Domain
por: Rodríguez, Yoel, et al.
Publicado: (2022)

Asparagus officinalis Exhibits Anti-Tumorigenic and Anti-Metastatic Effects in Ovarian Cancer
por: Xu, Guangxu, et al.
Publicado: (2021)

Small molecules that allosterically inhibit p21-activated kinase activity by binding to the regulatory p21-binding domain
por: Kim, Duk-Joong, et al.
Publicado: (2016)

Cooperation therapy between anti-growth by photodynamic-AIEgens and anti-metastasis by small molecule inhibitors in ovarian cancer
por: Dai, Jun, et al.
Publicado: (2020)

A novel small molecule inhibits STAT3 phosphorylation and DNA binding activity and exhibits potent growth suppressive activity in human cancer cells
por: Lin, Li, et al.
Publicado: (2010)

Identification of Selective Small Molecule Inhibitors of the Nucleotide-Binding Oligomerization Domain 1 (NOD1) Signaling Pathway
por: Rickard, David J., et al.
Publicado: (2014)

BET Bromodomain Inhibition as a Therapeutic Strategy in Ovarian Cancer by Downregulating FoxM1
por: Zhang, Zhenfeng, et al.
Publicado: (2016)

FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells
por: Chiu, Wen-Tai, et al.
Publicado: (2014)

The Anabaena sensory rhodopsin transducer defines a novel superfamily of prokaryotic small-molecule binding domains
por: De Souza, Robson F, et al.
Publicado: (2009)

Preliminary Discovery of Small Molecule Inhibitors of Epidermal Growth Factor Receptor (EGFR) That Bind to the Extracellular Domain
por: Di Liddo, Rosa, et al.
Publicado: (2022)

Prognostic significance of FOXM1 expression and antitumor effect of FOXM1 inhibition in synovial sarcomas
por: Maekawa, Akira, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_l6i3iivq0dj3t34ap7sem9etm7